$4.50
-0.95[-17.43%]
At close: Apr 24
$4.50
0[0.00%]
PreMarket: 8:00AM EDT
CalciMedica
(NASDAQ:CALC)CalciMedica Stock (NASDAQ:CALC), Analyst Ratings, Price Targets, Predictions
CalciMedica Inc has a consensus price target of $18.6, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, HC Wainwright & Co., and HC Wainwright & Co. on April 1, 2024, April 1, 2024, and March 13, 2024. With an average price target of $18 between Oppenheimer, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 300.00% upside for CalciMedica Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
HC Wainwright & Co.
HC Wainwright & Co.
JonesTrading
EF Hutton
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for CalciMedica
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/01/2024 | CALC | Buy Now | CalciMedica | $4.50 | 211.11% | Oppenheimer | Leland Gershell | $14 → $14 | Maintains | Outperform | Get Alert |
| 04/01/2024 | CALC | Buy Now | CalciMedica | $4.50 | 344.44% | HC Wainwright & Co. | Swayampakula Ramakanth | → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2024 | CALC | Buy Now | CalciMedica | $4.50 | 344.44% | HC Wainwright & Co. | Joseph Pantginis | → $20 | Reiterates | Buy → Buy | Get Alert |
| 02/16/2024 | CALC | Buy Now | CalciMedica | $4.50 | 388.89% | JonesTrading | Catherine Novack | → $22 | Initiates | → Buy | Get Alert |
| 02/13/2024 | CALC | Buy Now | CalciMedica | $4.50 | 344.44% | HC Wainwright & Co. | Joseph Pantginis | → $20 | Reiterates | Buy → Buy | Get Alert |
| 01/29/2024 | CALC | Buy Now | CalciMedica | $4.50 | 344.44% | HC Wainwright & Co. | Joseph Pantginis | → $20 | Initiates | → Buy | Get Alert |
| 11/13/2023 | CALC | Buy Now | CalciMedica | $4.50 | 211.11% | Oppenheimer | Leland Gershell | → $14 | Reiterates | Outperform → Outperform | Get Alert |
| 07/07/2023 | CALC | Buy Now | CalciMedica | $4.50 | 277.78% | EF Hutton | Tony Butler | → $17 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | CALC | Buy Now | CalciMedica | $4.50 | 277.78% | EF Hutton | Tony Butler | → $17 | Initiates | → Buy | Get Alert |
| 05/16/2023 | CALC | Buy Now | CalciMedica | $4.50 | 211.11% | Oppenheimer | Leland Gershell | → $14 | Reiterates | → Outperform | Get Alert |
| 03/24/2023 | CALC | Buy Now | CalciMedica | $4.50 | 211.11% | Oppenheimer | Leland Gershell | → $14 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for CalciMedica (CALC)?
The latest price target for CalciMedica (NASDAQ: CALC) was reported by Oppenheimer on April 1, 2024. The analyst firm set a price target for $14.00 expecting CALC to rise to within 12 months (a possible 211.11% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CalciMedica (CALC)?
The latest analyst rating for CalciMedica (NASDAQ: CALC) was provided by Oppenheimer, and CalciMedica maintained their outperform rating.
When was the last upgrade for CalciMedica (CALC)?
There is no last upgrade for CalciMedica.
When was the last downgrade for CalciMedica (CALC)?
There is no last downgrade for CalciMedica.
When is the next analyst rating going to be posted or updated for CalciMedica (CALC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CalciMedica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CalciMedica was filed on April 1, 2024 so you should expect the next rating to be made available sometime around April 1, 2025.
Is the Analyst Rating CalciMedica (CALC) correct?
While ratings are subjective and will change, the latest CalciMedica (CALC) rating was a maintained with a price target of $14.00 to $14.00. The current price CalciMedica (CALC) is trading at is $4.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.